Nova에 대한 매도 수량은 투자자에게 Nova의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Nova (NASDAQ:NVMI) 주식, 공매도 수량 보고

Nova

Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.

Nova Measuring

Equities

Large Cap

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Tech

ETFs

AAPL

ACLS

AVGO

MSFT

NVDA

NVMI

OLED

QRVO

SOXQ

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

인공 지능의 추진에 힘입어 반도체 기업들의 주가가 고공행진을 이어가고 있는 가운데, 현재 미국 칩 제조 산업은 총 가치가 6조 3천억 달러에 달한다. Invesco PHLX 반도체 ETF(NYSE:SOXQ)가 반영하는 필라델피아 반도체 지수(PHLX Semiconductor Sector Index)는 이번 주에 6% 상승할 것으로 예상되어 두 달 만에 가장 강력한 실적을 기록하고 사상 최고 수준을 달성했다.

반도체 업계가 $6조 3천억에 도달, 사상 최고 기록: 이번 주 엔비디아를 앞선 5개의 칩 주식

Nova Ltd

<ul>
<li>Expands applications' reach to&nbsp;backend semiconductor and Wafer Level Packaging, including Advanced Packaging.</li>
<li>All-cash transaction valued at approximately $60 million.</li>
<li>Acquisition expected to be accretive on non-GAAP net earnings basis within 12 months of closing.</li>
</ul>
REHOVOT, Israel, Nov. 27, 2024 /PRNewswire/ -- Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>)&nbsp;announced today that&nbsp;it has&nbsp;entered into a definitive&nbsp;agreement&nbsp;to acquire Sentronics Metrology GmbH, a privately held company headquartered in Mannheim Germany, in an all-cash transaction&nbsp;valued at&nbsp;approximately $60 million.

Nova Acquires Sentronics Metrology To Expand Its Dimensional Metrology Portfolio, In An All-Cash Transaction Valued At ~$60M

Benchmark analyst Mark Miller maintains Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Buy and raises the price target from $240 to $245.

News

Price Target

Analyst Ratings

Benchmark Maintains Buy on Nova, Raises Price Target to $245

Needham analyst Charles Shi reiterates Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Hold.

Reiteration

Needham Reiterates Hold on Nova

WIIM

Nova shares are trading higher after the company reported better-than-expected Q3 EPS and sales and provided Q4 revenue and EPS guidance above analyst estimates.

2024 Fourth Quarter Financial Outlook
Management provided an outlook for the fourth quarter, the period ending December 31, 2024. Based on current estimates, management expects:
<ul>
<li>$181 million to $191 million in revenue</li>
<li>$1.51 to $1.70 in diluted GAAP EPS</li>
<li>$1.72 to $1.91 in diluted non-GAAP EPS</li>
</ul>

Guidance

Nova Expects Q4 Revenue Of $181M-$191M Vs $171.84M Est, Adj EPS Of $1.72-$1.91 Vs $1.68 Est

Earnings

Earnings Beats

Nova Q3 2024 Adj. EPS $1.74 Beats $1.68 Estimate, Sales $178.974M Beat $171.840M Estimate

ARM,QCOM,NVDA,MU,AMD,TSM,AVGO,NXPI,LRCX,INTC,ASML,ON,RMBS,LSCC,GFS,TSEM,SIMO,ADI,KLAC,MCHP,STM,AMAT

ACMR

ALGM

AMAT

ASML

CAMT

ENTG

FORM

FSLR

INTC

KLAC

KLIC

LRCX

LSCC

MCHP

MKSI

MPWR

NXPI

QCOM

RMBS

SIMO

SITM

TSEM

UCTT

Shares of chip stocks are trading lower in sympathy with ASML, which fell after issuing soft guidance. Some stocks in the sector may also be down on reports indicating the US is discussing curbing chip exports to some countries.

AEHR

AMKR

CRDO

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MTSI

ONTO

SMTC

SWKS

Shares of semiconductor companies are trading higher amid overall market strength following Wednesday's Fed rate cut.

Nova shares are trading lower after Citigroup downgraded the stock from Buy to Neutral and lowered its price target from $273 to $224.

Citigroup analyst Atif Malik downgrades Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) from Buy to Neutral and lowers the price target from $273 to $224.

Downgrades

Citigroup Downgrades Nova to Neutral, Lowers Price Target to $224

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Monday.
Shares of iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) fell sharply in <a href="https://www.benzinga.com/quote/ITOS/analyst-ratings">today's pre-market trading.</a>
The company announced follow-up interim data from GALAXIES Lung-201.
iTeos Therapeutics shares dipped 13.7% to $14.40 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Vizsla Silver Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VZLA#NASDAQ">VZLA</a>) shares fell 11.4% to $1.94 in pre-market trading. Vizsla Silver announced a $65 million bought deal financing.</li>
<li>Murano Global Investments Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNO#NASDAQ">MRNO</a>) shares tumbled 11.1% to $8.89 in pre-market trading after jumping 36% on Friday.</li>
<li>Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) shares fell 8.5% to $34.79 in pre-market trading. Upstart announced a proposed private offering of $300,000,000 of convertible senior notes due 2029.</li>
<li>Guardant Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) shares dipped 8.2% to $24.60 in pre-market trading after gaining around 5% on Friday.</li>
<li>Hyliion Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYLN#NYSE">HYLN</a>) shares fell 6.7% to $1.96 in pre-market trading after gaining 8% on Friday. Hyliion Holdings, last week, announced it has been awarded a $15 million + contract by the Office of Naval Research to develop its KARNO generator for Navy ships and stationary power applications.</li>
<li>Instil Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) shares declined 6.1% to $79.40 in pre-market trading. Instil Bio and ImmuneOnco announced a global registrational strategy for PD-l1xvegf bispecific antibody, SYN-2510/IMM2510, in non-small cell lung cancer and triple-negative breast cancer.</li>
<li>Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) fell 5.6% to $1.01 in pre-market trading after jumping 15% on Friday.</li>
<li>Solid Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) shares slipped 3% to $7.70 in pre-market trading after adding around 3% on Friday.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) shares fell 3% to $200.64 in pre-market trading.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares slipped 2.4% to $138.10 in pre-market trading amid a drop in the price of Bitcoin. MicroStrategy shares gained over 8% on Friday after the company announced the purchase of 18,300 bitcoin.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40860420/jim-cramer-hold-on-to-builders-firstsource-heres-the-problem-with-viking-therapeutics">Jim Cramer: &#8216;Hold On&#8217; To Builders FirstSource, &#8216;Here&#8217;s The Problem&#8217; With Viking Therapeutics</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

HYLN

ITOS

MRNO

MSTR

SLDB

UPST

VZLA

iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM).
Nikola shares dipped 10.4% to $7.28 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) shares jumped 103% to $0.6719. Sify becomes first in India to achieve NVIDIA DGX-ready data center certification for liquid cooling to enable breakthrough AI performance.</li>
<li>BranchOut Food Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>) gained 85% to $3.70.</li>
<li>SPAR Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRP#NASDAQ">SGRP</a>) surged 65% to $2.3950 after the company announced it entered into a definitive agreement to be acquired by Highwire Capital for $2.50 per share.</li>
<li>Asset Entities Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) rose 62.7% to $2.31.</li>
<li>Conifer Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNFR#NASDAQ">CNFR</a>) shares jumped 56% to $1.0250 after the company announced that it completed the sale of its insurance agency operations for a $45 million consideration. The company appointed Brian Roney as CEO.</li>
<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) gained 44.6% to $1.25 after the company announced it recently launched both Apple CarPlay and Android Auto interfaces for its faidr mobile application.</li>
<li>Vaxcyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) surged 43.5% to $115.92 after the company announced it selected VAX-31 to advance to an adult Phase 3 program following topline results from its Phase 1/2 study.</li>
<li>Sable Offshore Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>) gained 28.8% to $21.69.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) rose 21.8% to $6.57 after the company received a favorable legal ruling from the U.S. ITC in its patent infringement complaint against Voltage, LLC and a related foreign entity.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) jumped 17.5% to $6.55 after the company announced it dosed 5 new patients in its ACHIEVE Phase 2b trial.</li>
<li>AGM Group Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) rose 16.5% to $1.27.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) gained 16% to $1.4150 after the company appointed former Stellantis executive Jean-Francois Mady as its new CFO.</li>
<li>Chemomab Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMMB#NASDAQ">CMMB</a>) surged 15.8% to $2.34.</li>
<li>MediciNova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNOV#NASDAQ">MNOV</a>) gained 15.3% to $1.73. MediciNova recently announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers MN-166 for post-COVID conditions.</li>
<li>GD Culture Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>) rose 12.8% to $6.86.</li>
<li>Big Tree Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSY#NASDAQ">DSY</a>) jumped 12.6% to $5.99.</li>
<li>Avalo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) gained 11.4% to $8.29.</li>
<li>Motorsport Games Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) rose 11.3% to $1.3250.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) gained 10.7% to $12.57 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $17 price target.</li>
<li>Unity Software Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) gained 9.4% to $17.91 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.</li>
<li>Intchains Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) climbed 8.1% to $7.89.</li>
<li>Keros Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) gained 8.1% to $49.04 after the company announced an update on enrollment in the Phase 2 TROPOS trial.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) gained 4.5% to $12.94. Friday, the FDA granted Emergency Use Authorization to Novavax Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in individuals aged 12 and older.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares dipped 42.2% to $4.68.</li>
<li>Dyne Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) fell 31.7% to $31.47. The company announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy who are amenable to exon 51 skipping demonstrating unprecedented dystrophin expression and functional improvement in multiple cohorts.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares fell 31.3% to $1.75 after jumping 60% on Friday.</li>
<li>IO Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) dipped 29.3% to $1.06 after the company announced the IDMC observed no new safety signals in the Phase 3 trial of IO102-IO103. Also, Morgan Stanley maintained an Overweight rating on the stock but lowered its price target from $7 to $4.</li>
<li>Brenmiller Energy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNRG#NASDAQ">BNRG</a>) fell 25.8% to $1.1499. Brenmiller recently reported a year-over-year increase in H1 EPS results. Also, the company announced a projected pipeline valued up to $500 million.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) dipped 22.8% to $1.13.</li>
<li>Four Seasons Education (Cayman) Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FEDU#NYSE">FEDU</a>) fell 21.8% to $13.30.</li>
<li>Quantum BioPharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) declined 21.6% to $3.55.</li>
<li>Applied DNA Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) fell 18.8% to $1.5506.</li>
<li>Xiao-I Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) dipped 18.6% to $3.99.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) fell 16.1% to $8.49.</li>
<li>LightInTheBox Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NASDAQ">LITB</a>) declined 14.3% to $0.4455.</li>
<li>NovoCure Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) fell 12.7% to $16.97 as the company announced planned CEO transition.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) fell 10.8% to $4.2350.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) declined 9.6% to $202.16.</li>
<li>Tidewater Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) fell 8.5% to $81.15.</li>
<li>Sterling Infrastructure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) fell 8.5% to $109.35.</li>
<li>The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) fell 8.3% to $159.27 ahead of the September 12 expiration of the company&#8217;s contract with the International Association of Machinists, which could lead to a potential strike. Additionally, Wells Fargo downgraded the stock from Equal-Weight to Underweight.</li>
<li>Avis Budget Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) dipped 8% to $75.43.</li>
<li>Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) fell 7.2% to $70.73.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) declined 7% to $20.52.</li>
<li>Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell 6.2% to $185.01.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40683473/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

Intraday Update

AAOI

AGMH

AIXI

APDN

ASST

ATPC

AUUD

AVTX

BNRG

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CNFR

FEDU

GERN

IOBT

KROS

LITB

MNOV

MRVL

MSGM

NVAX

NVCR

PCVX

PSNY

QNTM

RXRX

SGRP

SHLS

SIFY

SLXN

STRL

TCBP

WINT

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

ALAB

AMBA

AOSL

ASTI

DIOD

ENPH

INDI

LAES

NVTS

PLAB

POWI

SEDG

SKYT

SLAB

SYNA

Shares of semiconductor stocks are trading lower amid overall market weakness. A drop in the price of NVIDIA may weigh down the sector.

Benchmark analyst Mark Miller maintains Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Buy and raises the price target from $215 to $240.

Benchmark Maintains Buy on Nova, Raises Price Target to $240

U.S. stocks were higher, with the Dow Jones index gaining over 1% on Thursday.
Shares of Parker-Hannifin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) rose sharply during Thursday's session following better-than-expected fourth-quarter financial results and <a href="https://www.benzinga.com/quote/PH">upbeat FY25 guidance.</a>
Parker Hannifin reported fourth-quarter sales growth of 2% year over year to $5.186 billion and +3% organic growth, beating the consensus of $5.082 billion.
Parker-Hannifin shares jumped 9.8% to $562.79 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) gained 42.2% to $25.27 after the company reported better-than-expected first-quarter financial results.</li>
<li>XPEL, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) gained 35% to $42.65 after the company reported better-than-expected second-quarter financial results.</li>
<li>AxoGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) shares surged 33.5% to $10.57 after the company reported better-than-expected second-quarter results.</li>
<li>CommScope Holding Company, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) climbed 30% to $2.7600 after the company reported better-than-expected second-quarter financial results.</li>
<li>DocGo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCGO#NASDAQ">DCGO</a>) rose 27.1% to $3.80 after the company reported better-than-expected quarterly sales.</li>
<li>Klaviyo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) gained 25.2% to $28.91 after the company reported better-than-expected second-quarter financial results. Also, the company issued FY24 and Q3 revenue guidance above estimates.</li>
<li>Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) rose 23.3% to $3.4050 following upbeat quarterly earnings.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) gained 19.6% to $26.90 following second-quarter results.</li>
<li>Clean Energy Fuels Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) gained 19.2% to $2.8850 following quarterly earnings.</li>
<li>ICU Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICUI#NASDAQ">ICUI</a>) jumped 18.1% to $143.88 following strong quarterly results.</li>
<li>Under Armour, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UA#NYSE">UA</a>) gained 17.2% to $7.35 following first-quarter earnings.</li>
<li>SharkNinja, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) rose 16% to $84.65 after the company reported better-than-expected quarterly financial results.</li>
<li>Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) gained 15.5% to $46.61 after the company reported better-than-expected quarterly financial results.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) jumped 15% to $208.24 after the company reported better-than-expected second-quarter financial results and issued third-quarter guidance above estimates.</li>
<li>YETI Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) gained 13.1% to $41.90 after the company reported better-than-expected second-quarter financial results and raised its FY24 adjusted EPS guidance above estimates.</li>
<li>Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) rose 11.4% to $128.93 after the company reported better-than-expected first-quarter financial results.</li>
<li>Sealed Air Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) gained 10.6% to $38.04 following quarterly results.</li>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) rose 9.1% to $842.14 after the company reported better-than-expected second-quarter financial results and raised its full-year guidance.</li>
<li>ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) gained 5% to $69.63.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40253347/top-3-utilities-stocks-that-could-lead-to-your-biggest-gains-this-month">Top 3 Utilities Stocks That Could Lead To Your Biggest Gains This Month</a></li>
</ul>

AXGN

BOOT

CLNE

COMM

DCGO

FWRD

ICUI

KVYO

LESL

VSAT

XPEL

YETI

Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday

Nova shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates.

2024&nbsp;Third Quarter&nbsp;Financial&nbsp;Outlook
Management provided an&nbsp;outlook&nbsp;for the&nbsp;third quarter, the period ending&nbsp;September 30, 2024. Based on current estimates, management expects:
<ul>
<li>$168 million&nbsp;to&nbsp;$176 million&nbsp;in revenue</li>
<li>$1.39&nbsp;to&nbsp;$1.52&nbsp;in diluted GAAP EPS</li>
<li>$1.60&nbsp;to&nbsp;$1.73&nbsp;in diluted non-GAAP EPS</li>
</ul>

Nova Expects Q3 Revenue Of $168M-$176M Vs $148.1M Est, Adj EPS Of $1.60-$1.73 Vs $1.36 Est

Nova Q2 2024 Adj. EPS $1.61 Beats $1.36 Estimate, Sales $156.858M Beat $148.119M Estimate

AEIS

PDFS

VECO

WOLF

Shares of semiconductor stocks are trading lower in sympathy with Intel, which reported worse-than-expected Q2 financial results and issued soft guidance.

CEVA

CRUS

ICHR

WISA

Shares of chip stocks are trading lower amid overall market weakness. Recent earnings from large names in the sector may also be weighing on the sector.

Chips mostly rise as earnings fly in; Qualcomm gives up gains

Nova Measuring Instruments ( ($NVMI) ) has released its Q3 earnings. Here is a breakdown of the information Nova Measuring Instruments presented to...

Nova Measuring Instruments Reports Record Q3 2024 Results

In a report released yesterday, Vivek Arya from Bank of America Securities reiterated a Buy rating on Nova (NVMI – Research Report), with a price t...

Nova's Strategic Position and Growth Trajectory Highlighted in Vivek Arya's Buy Rating

Benchmark analyst Mark Miller raised the firm's price target on Nova (NVMI) to $245 from $240 and keeps a Buy rating on the shares after the compan...

Nova price target raised to $245 from $240 at Benchmark

Nova (NVMI – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Mark Miller from Benchmark Co. ...

Nova's Record Performance and Optimistic Growth Fuel Buy Rating

Nova: A New Trend May Have Presented Itself

Nova (NVMI) announced that it has entered into a definitive agreement to acquire Sentronics Metrology GmbH, a privately held company headquartered ...

Nova to acquire Sentronics Metrology for $60M in cash

Nova (NVMI) has released an update. Nova Ltd. has announced its acquisition of Sentronics Metrology for approximately $60 million, aiming to expand...

Nova Expands Metrology Portfolio with Sentronics Acquisition

Strategic Acquisition of Sentronics Boosts Nova's Semiconductor Market Position: A Buy Rating Justification

In a report released today, Vivek Arya from Bank of America Securities maintained a Buy rating on Nova (NVMI – Research Report). The company's shar...

Comments

Nova

매도 수량

Nova (NASDAQ:NVMI) 주식, 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌